Page last updated: 2024-09-05

azd2563 and rifampin

azd2563 has been researched along with rifampin in 2 studies

Compound Research Comparison

Studies
(azd2563)
Trials
(azd2563)
Recent Studies (post-2010)
(azd2563)
Studies
(rifampin)
Trials
(rifampin)
Recent Studies (post-2010) (rifampin)
290920,4681,4996,552

Protein Interaction Comparison

ProteinTaxonomyazd2563 (IC50)rifampin (IC50)
Polyunsaturated fatty acid lipoxygenase ALOX15Oryctolagus cuniculus (rabbit)2.949
Caspase-1Homo sapiens (human)8.319
Alpha-synucleinHomo sapiens (human)7.1
Enoyl-[acyl-carrier-protein] reductase [NADH]Mycobacterium tuberculosis H37Rv0.03
DNA-directed RNA polymerase subunit betaMycobacterium tuberculosis H37Rv0.01
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)1.5
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)1.5

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baulard, AR; Crauste, C; Déprez, B; Flipo, M; Villemagne, B; Willand, N1
Biava, M; Cocozza, M; Consalvi, S; Poce, G1

Reviews

2 review(s) available for azd2563 and rifampin

ArticleYear
Tuberculosis: the drug development pipeline at a glance.
    European journal of medicinal chemistry, 2012, Volume: 51

    Topics: Animals; Antitubercular Agents; Clinical Trials as Topic; Drug Discovery; Humans; Tuberculosis

2012
SAR analysis of new anti-TB drugs currently in pre-clinical and clinical development.
    European journal of medicinal chemistry, 2014, Oct-30, Volume: 86

    Topics: Animals; Antitubercular Agents; Humans; Mycobacterium tuberculosis; Structure-Activity Relationship; Tuberculosis; Tuberculosis, Multidrug-Resistant

2014